Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Pathophysiological Investigations Into Erdheim-Chester Disease

NCT01417520 is registered in ClinicalTrials.gov with National Human Genome Research Institute (NHGRI) as lead sponsor.

NCT NCT01417520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01417520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Pathophysiological Investigations Into Erdheim-Chester Disease
Lead sponsor
National Human Genome Research Institute (NHGRI)
Phase
Observational
Overall status
Completed
Start date
August 1, 2011
Completion date
July 24, 2019
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, gaucher disease, hermansky-pudlak syndrome (hps), myelofibrosis, pulmonary fibrosis